INMED PHARMACEUTICAL

IN
Delayed Toronto Stock Exchange - 06/02 09:55:33 pm
0.365CAD
+2.82%
Prev.0.3550
Open0.3500
High0.3650
Low0.3500
Volume67 475
Latest news
6d ago
7d ago
05/22
05/19
Graphique de cours
Technical analysis trends
Short TermMid-TermLong Term
TrendHaussireNeutralNeutral
Resistance0,380,380,39
Ecart / Rs.-2,7%-2,7%-5,2%
Spread/Supp.46%109%103%
Support0,250,180,18
Financials
Sales 2020 - - -
Net income 2020 -13,5 M -10,0 M -10,0 M
Net cash 2020 3,31 M 2,45 M 2,45 M
P/E ratio 2020 -4,56x
Yield 2020 -
Capitalization 62,9 M 46,6 M 46,5 M
EV / Sales 2019
EV / Sales 2020 -
Nbr of Employees 11
Free-Float 99,3%
Company
InMed Pharmaceuticals Inc. is a pre-clinical-stage biopharmaceutical company. The Company specializes in the research and development of cannabinoid-based therapies combined with drug delivery systems. The Company operates through the segment of research and development of pharmaceutical cannabis...
Sector :
Bio Therapeutic Drugs
Calendar :
2020-11-03 Earnings Release

Income Statement Evolution
Consensus
Mean consensus UNDERPERFORM
Number of Analysts 2
Average target price 0,45 CAD
Last Close Price 0,37 CAD
Spread / Highest target 23,3%
Spread / Average Target 23,3%
Spread / Lowest Target 23,3%